Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Macrophage activation syndrome in adult dermatomyositis: a case-based review
Dai Kishida, Noriko Sakaguchi, Ken‐ichi Ueno, et al.
Rheumatology International (2020) Vol. 40, Iss. 7, pp. 1151-1162
Closed Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Understanding and managing anti-MDA 5 dermatomyositis, including potential COVID-19 mimicry
Pankti Mehta, Pedro Machado, Latika Gupta
Rheumatology International (2021) Vol. 41, Iss. 6, pp. 1021-1036
Open Access | Times Cited: 82
Immunopathology of and potential therapeutics for secondary hemophagocytic lymphohistiocytosis/macrophage activation syndrome: a translational perspective
Tram Nguyen, Yoon Tae Kim, Geunyeol Jeong, et al.
Experimental & Molecular Medicine (2024) Vol. 56, Iss. 3, pp. 559-569
Open Access | Times Cited: 9
Rituximab in the Treatment of Interstitial Lung Diseases Related to Anti-Melanoma Differentiation-Associated Gene 5 Dermatomyositis: A Systematic Review
Chenjia He, Wenyu Li, Qibing Xie, et al.
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 27
Heterogeneity of macrophage activation syndrome and treatment progression
Yuanji Dong, Ting Wang, Huaxiang Wu
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
COVID-19 outcomes in patients with Dermatomyositis: A registry-based cohort analysis
Haig Pakhchanian, Hiba Khan, Rahul Raiker, et al.
Seminars in Arthritis and Rheumatism (2022) Vol. 56, pp. 152034-152034
Open Access | Times Cited: 15
Progressive, refractory macrophage activation syndrome as the initial presentation of anti-MDA5 antibody positive juvenile dermatomyositis: a case report and literature review
J. Alex Stewart, Theresa R. Price, Sam Moser, et al.
Pediatric Rheumatology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 12
Myositis-specific autoantibodies and their clinical associations in idiopathic inflammatory myopathies: results from a cohort from China
Lihong Wen, Xin Chen, Qi Cheng, et al.
Clinical Rheumatology (2022) Vol. 41, Iss. 11, pp. 3419-3427
Closed Access | Times Cited: 12
Macrophage activation syndrome in systemic lupus erythematosus and systemic-onset juvenile idiopathic arthritis: a retrospective study of similarities and dissimilarities
R Naveen, Avinash Jain, Hafis Muhammed, et al.
Rheumatology International (2021) Vol. 41, Iss. 3, pp. 625-631
Closed Access | Times Cited: 15
Efficacy of plasma exchange on top of standard immunosuppressive therapy in adult autoimmune inflammatory rheumatic diseases-associated macrophage activation syndrome, a single center real-world analysis
Yuxue Chen, Ziwei Hu, Shaozhe Cai, et al.
Seminars in Arthritis and Rheumatism (2022) Vol. 55, pp. 152043-152043
Closed Access | Times Cited: 11
Rare complications of anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis: Time to nip them in the bud
Jinming Yang, Bing Yan
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 10
Tocilizumab and rituximab for anti-MDA-5 positive amyopathic dermatomyositis complicated with macrophage activation syndrome and progressive fibrosing interstitial lung disease
C H Su, Hsien‐Tzung Liao, Chang‐Youh Tsai
Scandinavian Journal of Rheumatology (2021) Vol. 51, Iss. 2, pp. 166-168
Closed Access | Times Cited: 11
Anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis complicated with macrophage activation syndrome
Yukang Ding, Yongpeng Ge
Therapeutic Advances in Chronic Disease (2022) Vol. 13
Open Access | Times Cited: 7
Clinical features of macrophage activation syndrome in adult dermatomyositis: A single‐center retrospective case‐control study
Dingxian Zhu, Shuni Ying, Changyi Yang, et al.
Immunity Inflammation and Disease (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 1
Macrophage activation syndrome in MDA5 antibody-positive dermatomyositis and COVID-19 infection
Marzieh Keshtkar‐Jahromi, Sumit Bahadur Baruwal Chhetri, Amulya Balagani, et al.
BMC Rheumatology (2021) Vol. 5, Iss. 1
Open Access | Times Cited: 9
Macrophage activation syndrome in juvenile dermatomyositis: a case report and a comprehensive review of the literature
Yong Chang, Xueyan Shan, Yongpeng Ge
Pediatric Rheumatology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 3
Clinical Value of 18F-FDG PET/CT Scan and Cytokine Profiles in Secondary Hemophagocytic Lymphohistiocytosis in Idiopathic Inflammatory Myopathy Patients: A Pilot Study
Junyu Liang, Heng Cao, Bowen Wu, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 7
Update in Hyperferritinemic Syndromes: Recognition and Management - A Scoping Review
Athanasios Vassilopoulos, Winston McCormick, Alisha Lakhani
Journal of Brown Hospital Medicine (2022) Vol. 1, Iss. 3
Open Access | Times Cited: 5
Complication of coronavirus disease 2019 during remission induction therapy against anti-MDA5 antibody-positive dermatomyositis
Masahiro Kogami, Satoshi Suzuki, Yuta Nanjo, et al.
Rheumatology Advances in Practice (2020) Vol. 4, Iss. 2
Open Access | Times Cited: 6
Clinical significance of HScore and MS score comparison in the prognostic evaluation of anti-MDA5-positive patients with dermatomyositis and interstitial lung disease
Shengnan Zhao, Xiaolei Ma, Xin Zhang, et al.
Modern Rheumatology (2021) Vol. 32, Iss. 2, pp. 373-379
Closed Access | Times Cited: 5
Hepatic veno-occlusive disease accompanied by thrombotic microangiopathy developed during treatment of juvenile dermatomyositis and macrophage activation syndrome: A case report
Mariko Mouri, Toru Kanamori, Eriko Tanaka, et al.
Modern Rheumatology Case Reports (2022) Vol. 7, Iss. 2, pp. 404-409
Closed Access | Times Cited: 3
Increased serum soluble interleukin-2 receptor levels in dermatomyositis are associated with Th17/Treg immune imbalance
Yuhuan Xie, Tingting Zhang, Rui Su, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 1
An Unusual Case of Macrophage Activation Syndrome (MAS)- Hemophagocytic Lymphohistiocytosis (HLH) Triggered by Necrotizing Autoimmune Myopathy
Tyiesha S Brown, Gregory Vo, Prangthip Charoenpong
Cureus (2023)
Open Access | Times Cited: 1
Macrophage Activation Syndrome in the Setting of Rheumatic Diseases
Winn Chatham
Advances in experimental medicine and biology (2024), pp. 399-408
Closed Access
Secondary immune thrombocytopenia with elevated serum ferritin in a patient with anti-MDA5 antibody-positive dermatomyositis
Yohsuke Oto, Takashi Shimoyama, Taro Ukichi, et al.
Lara D. Veeken (2021) Vol. 61, Iss. 2, pp. e40-e42
Closed Access | Times Cited: 2
Hämophagozytische Syndrome beim Erwachsenen
Thomas Schenk, Sebastian Birndt, Paul La Rosée
Aktuelle Rheumatologie (2020) Vol. 45, Iss. 06, pp. 550-558
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top